Your validation protocols for the execution ofrevalidation studies do not specify critical process steps.
Inspection Record
Central Glass Co., Ltd. — FDA 483 Findings
Inspectors Teresa I. NavasThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Your receiving procedures for raw materials are inadequate.
Laboratory Controls are inadequate.
Changes that could affect the production and control of the intermediate or API are not always handled using the formal change control system.
Your cleaning procedures are not validated.
Specifications of Water used in the manufacture of APIs do not demonstrate the water is suitable for its intended use.
A record as of the US FDA document published on 2026-11-05. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.